Users of the Dexcom G5 Mobile Continuous Glucose Monitoring System (Dexcom G5) can now rely on the device to make diabetes treatment decisions using two finger pricks daily, not multiple ones, following the U.S. Food and Drug Administration’s (FDA) approval of expanded use of the device.
On Tuesday, the FDA granted the expanded indication. Users must still calibrate the device at least two times a day by testing a fingertip blood sample with a blood glucose meter.
Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.